Pharmaceutical Technology ePT Weekly
Having trouble viewing this e-mail? CLICK HERE
PharmTech
April 20, 2017
PHARMTECH.COM CURRENT ISSUE SUBSCRIBE FORWARD
advertisement

In this issue:

Baby Teething Tablets Recalled

Janssen Deal with PeptiDream

Organic and Elemental Impurities

Top Stories

UC Berkeley Appeals CRISPR Decision

UC Berkeley appealed the February 2017 decision that determined Harvard and MIT's Broad Institute and Berkeley's CRISPR-Cas9 technologies were separately patentable.
/ read more /


Bristol-Myers Squibb Inks Licensing Deals with Biogen, Roche

BMS is licensing two investigational compounds in separate deals with Roche and Biogen for a total of $470 million in upfront payments.
/ read more /

advertisement
advertisement

Subscribe

Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.

subscription offers
subscribe

PODCAST

Barry Holtz, president, iBio CMO sat down with Pharmaceutical Technology to discuss plant models in biopharmaceutical manufacturing.

Listen Now
advertisement

Pharmaceutical Technology's PharmaMarketplace
Your Connection to Global Pharmaceutical Manufacturing Suppliers
Check it out today!


Industry News

Remaining Hyland Baby Teething Tablets Recalled

Standard Homeopathic Company is recalling all lots of Hyland's Baby Teething Tablets and Hyland's Nighttime Baby Teething Tablets due to inconsistent amounts of belladonna alkaloids.
/ read more /


EMA Updates Flu Vaccination Recommendations

The agency issued its recommendation for the influenza virus strains European vaccine manufacturers should include for 2017.
/ read more /


More Industry News

Supplier News

Bristol-Myers Squibb and Nordic Bioscience Collaborate on Fibrosis Biomarker Technology

The two companies will develop translational biomarkers for fibrotic diseases, including non-alcoholic steatohepatitis (NASH).
/ read more /


Uhlmann Packaging Systems Joins Serialization Standardization Group

Uhlmann Packaging Systems joined the OPC Foundation's Open Serialization Communication Standard (OPEN-SCS) Working Group.
/ read more /


More Supplier News

advertisement

Best Practices for Extractables and Leachables Testing for Primary Drug Product Packaging
Live Webcast: Wednesday, May 24 at 11:00am EDT and Wednesday, May 31 at 11:00am CEST
Register now


Bio/Pharma News

Janssen Signs Deal with PeptiDream

Janssen will have access to PeptiDream's proprietary Peptide Discovery Platform System technology, which will be used to identify peptides against multiple metabolic and cardiovascular targets.
/ read more /


Additional Data Needed for Incyte’s Baricitinib

FDA denies the NDA for the RA drug developed by Eli Lilly and Incyte, citing the need for more data.
/ read more /


More Bio/Pharma News

Regulatory News

Modernizing Organic and Elemental Impurities

At CPhI North America 2017, the US Pharmacopeial Convention will be discussing its upcoming revision and modernization of the standards for elemental and organic impurities.
/ read more /


Former CDER OSI Associate Director for Risk Science to Speak at CPhI North America 2017

Pharmaceutical Technology spoke with CPhI North America presenter Jonathan Helfgott to discuss navigating GDUFA and helpful tips for submitting successful ANDAs.
/ read more /


More Regulatory News

advertisement

Driving compounds forward
Every molecule presents its own set of challenges. Capsugel's unique combination of drug and process design capabilities – coupled with premier depth in bioavailability enhancement and targeted delivery technologies – enable us to deliver the right solution for meeting those challenges.
To learn more visit www.capsugel.com.

FEATURED TOPICS

FORMULATION

Developing cannabis-based therapeutics

David Fulper, PhD, director of technology support at Catalent, shares insights on the challenges and opportunities for cannabis-based therapeutics.
/ read more /

MANUFACTURING

Key parameters to be optimized in the development and manufacturing of oral solid-dosage forms

Anil Kane, executive director, Global Head of Formulation Sciences, Pharmaceutical Development Services at Patheon discusses key parameters in the development and manufacturing of oral solid-dosage forms.
/ read more /

TROUBLESHOOTING

Automating Bioprocesses

The process control and automation requirements of single-use systems differ from those of stainless-steel equipment.
/ read more /

QUALITY

Critical Quality Attributes Challenge Biologics Development

The complex nature of biologics adds additional CQAs that must be determined to ensure the safe development of biologics.
/ read more /


CPhI North America Planning Guide

Emergent BioSolutions

Emergent provides contract manufacturing services for the aseptic fill/finish of vials and syringes: liquid and lyophilized products.
CPhI North America Booth #3005
/ Learn more /

Federal Equipment Company

Thinking about equipment? Federal Equipment Company delivers huge price and lead time savings when you are sourcing top-brand pharmaceutical processing and packaging equipment for your operations.
CPhI North America Booth #2125
/ Learn more /

Jost Chemical Co.

For more than 30 years, Jost Chemical Co. has manufactured high purity chemical salts for the pharmaceutical, biopharmaceutical, and nutritional markets.
CPhI North America Booth #2559
/ Learn more /

Patheon

Patheon, a business unit of DPx Holdings B.V., is a leading provider of contract development and commercial manufacturing services to the pharmaceutical and biotechnology sectors.
CPhI North America Booth #2815
/ Learn more /

Procaps

Softigel by Procaps offers Contract Manufacturing & Product Development services in advanced softgel technologies, focusing on difficult-to-produce compounds, unique formulations, innovative dosage forms, and non-traditional manufacturing processes.
CPhI North America Booth #2613
/ Learn more /

Suheung Capsule

Widely recognized global supplier of two piece capsules, Suheung Capsule has solely focused on manufacturing the highest quality Capsules.
CPhI North America Booth #2733
/ Learn more /


UPCOMING WEBCASTS

A Complete Guide to USP <232> & <233> Pharmaceutical Elemental Impurities – Implementing Pharmaceutical Elemental Impurity Sample Preparation and Analysis
Live Webcast: Wednesday, May 10 at 11:00am EDT
Register now


A Complete Guide to USP <232> & <233> Pharmaceutical Elemental Impurities – Understanding Pharmaceutical Elemental Impurity Regulations and Laboratory Considerations
Live Webcast: Thursday, April 20 at 11:00am EDT
Register now


Events

ExcipientFest Americas

April 24–26, 2017

Making Pharmaceuticals

April 25–26, 2017

CPhI North America

May 16–18, 2017

more events

REFERENCE BOOKS

Pharmaceutical Technology presents its Analytical Testing Resource Guide combo

A compilation of articles in a three-handbook set covering general Analytical Testing and Stability in the manufacture, packaging, storing, and testing of formulated products.
/ Click here /

More Reference Library

eBOOKS

Quality Throughout the Supply Chain

Quality issues can appear at any stage of the bio/pharmaceutical development and manufacturing supply chain. Drug companies must monitor raw materials, suppliers, contract service providers, facilities, manufacturing processes, and production workers. In this e-book, the editors examine current quality issues, and how the industry is addressing quality challenges throughout the supply chain.


contribute | contact editors | CONTACT SALES | subscribe | advertise